Christopher Mortko, PhD, MBA
Christopher Mortko Ph.D., MBA is an Associate Vice President and Head of Search and Evaluation in the Business Development and Licensing organization at Merck.
In this role, Chris leads a team responsible for the search, scientific evaluation, and due diligence for clinical stage research and development opportunities across all therapeutic areas and enabling technologies. He is a key member of Merck’s Business Development governance committee that is responsible for decision making and deal structure/terms for business development opportunities.
Prior to joining Merck business development, Christopher was a Senior Biotechnology Equity Analyst on Wall Street, focusing on oncology, immunology, and other therapeutic areas. Earlier in his career he was a research scientist at Merck and Amgen involved in drug discovery and development across a number of therapeutic areas including oncology.
Christopher received his undergraduate education at Fordham University in New York. He received a PhD in Organic Chemistry from the University of California, Los Angeles and completed an MBA at the NYU Stern School of Business.